Therapeutics News and Research

RSS

Ancient proteins revived to inspire new antimicrobial treatments

University of Oregon biologists have resurrected prehistoric proteins up to 160 million years old that carry natural antimicrobial properties.

25 Aug 2026

Diabetes study reveals differing health risks for men and women

In the years following type 2 diabetes diagnosis, women are more likely to develop mental health conditions, while men are more likely to develop cardiovascular and renal complications, according to a study published August 25th in the open access journal PLOS Medicine by Fabiola Eto from Queen Mary University of London, UK, and colleagues.

25 Aug 2026

Study reveals high prevalence of chronic traumatic encephalopathy among former NFL players

At minimum, nearly a quarter of all former National Football League (NFL) players who died from 2016 to 2021 had confirmed chronic traumatic encephalopathy (CTE) – a neurodegenerative disease linked to repeated head impacts – at death, finds a study published by The BMJ today.

25 Aug 2026

New study makes progress in understanding the mechanisms behind severity of HFpEF

Approximately 3 million people in the United States are living with a condition called heart failure with preserved ejection fraction, or HFpEF.

24 Aug 2026

UC Berkeley researchers find new potential treatment for obesity and diabetes

Over the past five years, medications called GLP-1s have revolutionized the treatment of metabolic disorders like obesity, diabetes and fatty liver diseases.

21 Aug 2026

Glioma microenvironment emerges as key target for future therapies

The prognosis for glioma patients remains extremely poor despite aggressive multimodal standard therapy: maximal safe resection, radiotherapy, and temozolomide chemotherapy, with median survival rarely exceeding 15 to 18 months.

20 Aug 2026

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The ELRIG Mid-Career Initiative supports scientists in drug discovery, addressing unique challenges and fostering leadership development for career transitions.

20 Aug 2026

Red blood cells inspire next-generation therapeutic nanocarriers

Red blood cells serve as the foundation for nanocarriers that show promise in a new study as effective and efficient vehicles for gene therapy, tumor targeting and other medical treatments.

19 Aug 2026

Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model

Qureight, an end-to-end imaging company that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, today announced the opening of its new office space in London, UK.

From Qureight 19 Aug 2026

Habitual pork consumption supports clinically meaningful weight loss, study finds

According to a peer-reviewed study published May 29, 2026 in Nutrition & Diabetes, adults with overweight or obesity (mean BMI: 33.6 kg/m²; mean age: 47.7 years) who reported continuing to eat pork while participating in a 6-month digital weight management program lost a clinically significant 5.3% of starting body weight and improved their overall diet quality scores by 4.3 points.

18 Aug 2026

Study provides new insights into how IL-26 reshapes the tumor immune landscape

While cancer cells acquire malignant traits through epigenetic remodeling, it remains unclear how immune-derived inflammatory factors regulate the epigenetics of colorectal cancer cells.

18 Aug 2026

Laser treatment may extend survival in glioblastoma patients

For patients facing a diagnosis of glioblastoma - one of the most aggressive and devastating forms of brain cancer - the standard path forward has long meant an invasive open-skull surgery and a daunting prognosis.

17 Aug 2026

Engineered red blood cell vesicles improve gene therapy delivery

Red blood cells serve as the foundation for nanocarriers that show promise in a new study as effective and efficient vehicles for gene therapy, tumor targeting and other medical treatments.

17 Aug 2026

Japanese research team named a Milestone 2 Awardee of the XPRIZE Healthspan competition

A research team led by Professor Keisuke Goda of the SiRIUS Institute of Medical Research and Graduate School of Medicine at Tohoku University, together with the Department of Chemistry at the University of Tokyo, has been named a Milestone 2 Awardee of the XPRIZE Healthspan competition - one of the world's largest health research competitions.

17 Aug 2026

Placental biology breakthrough could make biologic medicines safer during pregnancy

Biologic medicines have transformed the treatment of cancer, autoimmune diseases, migraine, inflammatory disorders and many other diseases.

14 Aug 2026

New microscope tracks electrical activity across the brain on the scale of milliseconds

Within the brain, neurons compute by generating electrical impulses. These signals travel throughout neurons, which are in turn connected in vast networks that control brain functions such as sensory perception, memory formation, and control of movement.

14 Aug 2026

Weizmann study reveals how DNA repair enzymes choose targets

When a wound does not heal properly, it leaves a scar. Similarly, mutations – which are permanent changes to genetic code – are often the result of damaged DNA that has not been properly repaired.

14 Aug 2026

Targeting single gene reverses developmental deficits in adult mice

Some of the symptoms of neurodevelopmental disorders (NDDs) such as autism spectrum disorder and epilepsy may result from dysfunction of certain neurons in the brain and their ability to change their properties in response to experiences-a process called experience-dependent plasticity.

12 Aug 2026

Genetic tool turns soft cancer cells into immune targets

Researchers at the USC Viterbi School of Engineering and Keck School of Medicine of USC have engineered a remarkable genetic tool that addresses one of the most persistent obstacles in cancer immunotherapy: the physical softness of tumors.

11 Aug 2026

Shared cellular pathway drives neurodegeneration in rare childhood dementia and Alzheimer’s

Researchers at University of California San Diego and their colleagues have identified a key cellular pathway that drives brain degeneration in both a rare childhood disorder and the far more common Alzheimer's disease.

11 Aug 2026

Therapeutics News and Research

Ancient proteins revived to inspire new antimicrobial treatments

Diabetes study reveals differing health risks for men and women

Study reveals high prevalence of chronic traumatic encephalopathy among former NFL players

New study makes progress in understanding the mechanisms behind severity of HFpEF

UC Berkeley researchers find new potential treatment for obesity and diabetes

Glioma microenvironment emerges as key target for future therapies

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Red blood cells inspire next-generation therapeutic nanocarriers

Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model

Habitual pork consumption supports clinically meaningful weight loss, study finds

Study provides new insights into how IL-26 reshapes the tumor immune landscape

Laser treatment may extend survival in glioblastoma patients

Engineered red blood cell vesicles improve gene therapy delivery

Japanese research team named a Milestone 2 Awardee of the XPRIZE Healthspan competition

Placental biology breakthrough could make biologic medicines safer during pregnancy

New microscope tracks electrical activity across the brain on the scale of milliseconds

Weizmann study reveals how DNA repair enzymes choose targets

Targeting single gene reverses developmental deficits in adult mice

Genetic tool turns soft cancer cells into immune targets

Shared cellular pathway drives neurodegeneration in rare childhood dementia and Alzheimer’s

Event guide: The Non-Opioid Pain Therapeutics Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News